Serial #79304500
LIVE

Serial Number

79304500

Owner

Lucine

Attorney

Rebeccah Gan

Filing Date

Nov 6, 2020

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79304500 Trademark

Serial Number: 79304500 • Registration: 6648851

Serial #79304500 is a trademark filed by Lucine on November 6, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Lucine (6 trademarks)

Bassins à flots
Bordeaux 33300 , FR

Entity Type: 03

Trademark Details

Filing Date

November 6, 2020

Registration Date

February 22, 2022

Published for Opposition

December 7, 2021

Goods & Services

Scientific apparatus and instruments for measuring relative DNA, RNA and protein and parts and fittings therefor; Diagnostic apparatus for the detection of pathogens for laboratory or research use; Downloadable computer software for collecting, analyze, monitor and manage data to prevent, manage and treat chronic pain and medical disorder or disease; downloadable software applications for collecting, analyze, monitor and manage data to prevent, manage and treat chronic pain and medical disorder or disease ; downloadable data processing computer software; downloadable software for medical use for collecting, analyze, monitor and manage data to prevent, manage and treat chronic pain and medical disorder or disease; Downloadable computer software using artificial intelligence for collecting, analyze, monitor and manage data to prevent, manage and treat chronic pain and medical disorder or disease; downloadable computer application software for transmitting, receiving and analyzing video communications, two-way video, voice and text conferencing for collecting health-related data, diagnosing pain, defining treatment based on the diagnosis and administering appropriate pain treatment, either directly to the patient, the healthcare professional or the pharmaceutical entity; downloadable computer application software for measuring, analyzing, preventing, alleviating and managing pain; downloadable database management software; downloadable computer software for enabling the searching and retrieval of data; downloadable databases in the field of the relief of pain; data processing apparatus; electronic data processing apparatus

Pharmaceutical products and preparations for treating chronic pain; medical and veterinary preparations for treating chronic pain; medicines for treating chronic pain; medicinal preparations and substances for treating chronic pain; pharmaceutical preparations and substances for treating chronic pain; diagnostic reagent substances for medical use; reagents and preparations for medical and veterinary diagnostic purposes; preparations for the relief of pain

Medical and health care services; medical services in the field of chronic pain treatment; telemedicine services; advisory services relating to health care; medical diagnostic testing and analysis services; medical evaluation services of pain; conducting of pain studies for medical diagnostic or treatment purposes; medical information; provision of health care information in the field of prevention, screening, diagnosis and treatment of pain; health care services, namely, providing therapeutic treatment of pain; health care services, namely, therapeutic services against pain; health care services, namely, providing therapeutic treatment of pain via the internet

Medical apparatus and instruments for treating pain; medical diagnostic apparatus and instruments for treating chronic pain; tools for medical diagnosis for treating chronic pain; medical instruments for monitoring vital signs of patients; pain measuring device for medical use; pain analysis device for medical use; instruments for medical use for use in treating pain; medical apparatus and instruments, namely, pain relief instruments for medical use

Scientific research and development; medical and pharmacological research services; Technical research in the field of pharmaceutical studies; biological, clinical and medical research services in the field of pain management; research and development of new products; medical research laboratory; laboratory testing services, namely, laboratory analysis in the field of pain management; scientific research and analysis; research and development relating to software; Outsource service providers in the field of information technology; new product design services, namely, design and development of medical technologies; development of databases; maintenance of database software; technical project studies, namely, scientific study and research in the field of pain management; technical research in the field of software, namely, project studies concerning software; design and development of software for use in the framework of medical technology; Software as a service (SAAS) services for medical use featuring software for collecting, analyze, monitor and manage data to prevent, manage and treat chronic pain and medical disorder or disease; application service provider (ASP), namely, hosting software as a service (SAAS) software of others in the field of digital health services; Software as a service (SAAS) services, namely, hosting software for use by others for collecting, analyze, monitor and manage data to prevent, manage and treat chronic pain and medical disorder or disease; computer platform as a service (PaaS) featuring software platforms for transmission of images, audiovisual content, video content and messages; computer programming; design and development of software application solutions; design and development of medical diagnostic apparatus; design and development of computer hardware and software for use in the medical field; development of data processing programs; electronic data storage and backup services; Information technology (IT) consulting services in the field of securing computer data; technical data analysis services, namely, compiling data for research purposes in the field of medical science and medical consultancy; provision of information relating to medical and scientific technology research; provision of information and data relating to medical and veterinary research and development; information technology (IT) consulting services, namely, advice relating to information technology intended for the pharmaceutical and health industries

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 22, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jul 29, 2022 FICS
FINAL DISPOSITION PROCESSED
Jul 29, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 22, 2022 FICR
REGISTERED-PRINCIPAL REGISTER
Feb 22, 2022 R.PR
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 26, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 26, 2021 TCCA
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 26, 2021 COAR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 16, 2021 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Dec 16, 2021 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 16, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 16, 2021 REAP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 7, 2021 NPUB
PUBLISHED FOR OPPOSITION
Dec 7, 2021 PUBO
NOTIFICATION PROCESSED BY IB
Dec 6, 2021 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 17, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 17, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 17, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 29, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 29, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 29, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 29, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 29, 2021 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 25, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 24, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 24, 2021 TROA
NEW REPRESENTATIVE AT IB RECEIVED
Jul 16, 2021 NREP
REFUSAL PROCESSED BY IB
May 17, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 28, 2021 RFCS
REFUSAL PROCESSED BY MPU
Apr 28, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 24, 2021 RFCR
NON-FINAL ACTION WRITTEN
Apr 23, 2021 CNRT
ASSIGNED TO EXAMINER
Apr 14, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 27, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 23, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 18, 2021 REPR